Your AI-Trained Oncology Knowledge Connection!
Video
Author(s):
Panel of experts discuss where CAR T-cell therapy might fit into the treatment landscape for patients with R/R DLBCL.
Apr 24th 2025 - Apr 25th 2026
Apr 23rd 2025 - Apr 24th 2026
Apr 23rd 2025 - Apr 24th 2026
Apr 28th 2025 - Apr 29th 2026
Apr 28th 2025 - Apr 29th 2026
Apr 24th 2025 - Apr 25th 2026
Apr 23rd 2025 - Apr 24th 2026
Apr 23rd 2025 - Apr 24th 2026
Apr 28th 2025 - Apr 29th 2026
Apr 28th 2025 - Apr 29th 2026
Apr 24th 2025 - Apr 25th 2026
Apr 23rd 2025 - Apr 24th 2026
Apr 23rd 2025 - Apr 24th 2026
Dr Loong on the Efficacy of D3S-001 in KRAS G12C Inhibitor–Resistant NSCLC
Avutometinib/Abemaciclib/Fulvestrant Combo Is Active, Safe in CDK4/6 Inhibitor–Resistant HR+/HER2– Metastatic Breast Cancer
SYN818 Shows Favorable Safety Profile in Locally Advanced or Metastatic Solid Tumors
Runimotamab Plus Trastuzumab Is Active and Tolerable in HER2+ Breast Cancer
2 Commerce Drive
Cranbury, NJ 08512